COYA
NASDAQ
US
Coya Therapeutics, Inc. - Common Stock
$4.01
▼ $-0.07
(-1.72%)
Vol 76K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$121.4M
ROE
-57.4%
Margin
-462.3%
D/E
0.00
Beta
0.24
52W
$5–$8
Wall Street Consensus
13 analysts · Apr 20263
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
92.3%
Buy Rating
Price Chart
Similar Stocks
CADL
Candel Therapeutics Inc
$310.2M
ALDX
Aldeyra Therapeutics Inc
$99.9M
SPRB
Spruce Biosciences, Inc
$93.2M
QTTB
Q32 Bio Inc
$40.9M
PYXS
Pyxis Oncology Inc
$71.6M
RCEL
AVITA Medical Inc
$105.2M
MCRB
Seres Therapeutics Inc
P/E 25.0
$134.6M
GOSS
Gossamer Bio Inc
$717.5M
HURA
TuHURA Biosciences Inc
$45.9M
Earnings
Beat rate: 60.0%
Next Report
May 11, 2026
EPS Estimate: $-0.42
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.42 | — | — |
| Dec 2025 | $-0.28 | $-0.34 | $-0.06 |
| Sep 2025 | $-0.28 | $-0.13 | +$0.15 |
| Jun 2025 | $-0.40 | $-0.36 | +$0.04 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -61.0% | -61.1% | -61.1% | -61.1% | -57.4% | -57.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -3725.1% | -3853.5% | -3853.5% | -3853.5% | -462.3% | -462.3% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 7.43 | 7.43 | 7.43 | 7.43 | 8.73 | 8.73 |
Key Ratios
ROA (TTM)
-49.7%
P/S (TTM)
30.43
P/B
2.4
EPS (TTM)
$-1.11
CF/Share
$-1.22
52W High
$8.29
52W Low
$4.65
$4.65
52-Week Range
$8.29
How does COYA compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
COYA valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
30.4
▲
137%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
2.4
▼
2%
below
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
COYA profitability vs Biotechnology peers
ROE
-57.4%
▲
15%
above
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
-462.3%
▼
61%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-49.7%
▼
6%
below
peers
(-46.7%)
vs Peers
vs Industry
In line
COYA financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.7
▲
97%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.2
▼
75%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
COYA fundamentals radar
COYA
Peer median
Industry
COYA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
COYA vs peers: key metrics
Latest News
No related news yet